Homoeopathic treatment of pain and stiffness of small joints

Individualized Homoeopathic Medicines in Treatment of Rheumatoid Arthritis: Double-blind, Randomized, Placebo-controlled, Pilot Trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028622

Enrollment

Registered

2020-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies, as decided appropriate

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from eating, drinking, smoking or brushing teeth within 30 minutes of taking the globu

adequate rest, physical activity and exercise, and will be advised to be present for monthly follow-ups. Route of administration: oral. Duration of therapy: 3 months. Control Intervention1: Placebo: T

dosage and repetition will be depending upon the individual requirement of the cases. Patients will be advised to refrain from eating, drinking, smoking or brushing teeth within 30 minutes of taking t

adequate rest, physical activity and exercise, and will be advised to be present for monthly follow-ups. Route of administration: oral. Duration of therapy: 3 months.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having scored 6 or higher according to the ACR (American College of Rheumatology) criteria for classification of rheumatoid arthritis. 2. Patients of either sex. 3. Age between 18-65 years. 4. Patients with known but controlled systemic diseases are also eligible for the study. 5. Literate patients; ability to read Bengali and/or English. 6. Patients giving written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with psychiatric diseases 2. Cases suffering from uncontrolled systemic illness, life-threatening infections, or any vital organ failure 3. Cases already undergoing homoeopathic treatment for any chronic purpose since last 6 months 4. Substance abuse and/or dependence 5. Self-reported immune-compromised state 6. Women during pregnancy, puerperium and lactation

Design outcomes

Primary

Measure	Time frame
Disease Activity Index 28 (DAS28) scoresTimepoint: Baseline and after 3 months	—

Secondary

Measure	Time frame
Rheumatoid Arthritis Disease Activity Index (RADAI)Timepoint: Baseline and after 3 months	—

Countries

India

Contacts

Public ContactProf Dr Rajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026